Abstract We determined the genomic structure of the human gene encoding 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which catalyzes the conversion of HMG-CoA to mevalonate and is the rate-limiting and major regulatory enzyme in sterol biosynthesis. The gene is more than 21 kb long, about five times the size of its corresponding cDNA. It consists of 20 exons, ranging in size from 68 to 1809 bp. An amino-terminal hydrophobic membrane-bound domain is encoded by exons 2-10, a flexible linker domain by exons 10 and 11, and the catalytic domain by exons 11-20. Exons 3-7 encode a sterol-sensing domain. We compared its genomic structure in this region with the sterol-sensing domains of three related genes, sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP), Niemann-Pick type C1 protein (NPC1), and a morphogen receptor, Patched. Two of the five positions of introns in the sterol-sensing domain of the HMG-CoA reductase gene were identical to the exon/intron organization of this domain in the related human genes, but these positions of introns were not conserved in homologues from lower organisms, except in one instance. The data suggested that exon-shuffling may have occurred during relatively recent evolution; this would account for the structural similarity of this domain in four quite different human proteins. 
Introduction
HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, is the rate-limiting and major regulatory enzyme in sterol biosynthesis (Goldstein and Brown 1990) . The complex system regulating levels of this enzyme in tissues involves both transcription of the gene and degradation of the protein (Gil et al. 1985; Luskey and Stevens 1985) . HMG-CoA reductase is normally a relatively stable, slowly degraded enzyme, but in the presence of excess sterols it is degraded rapidly and selectively. Its membrane-bound domain plays a crucial role in regulating the degradation of this protein.
A sequence motif spanning five consecutive transmembrane regions is present in HMG-CoA reductase, and also in three distinctively different proteins: SREBP (sterol regulatory element binding protein) cleavageactivating protein (SCAP; Hua et al. 1996; Nohturfft et al. 1998) ; Niemann-Pick type C1 protein (NPC1), a defective protein in Niemann-Pick disease Loftus et al. 1997) ; and Patched, a morphogen receptor in Drosophila, and a defective protein in human basal cell nevus syndrome (Johnson et al. 1996; Hahn et al. 1996) . This motif appears to function as a sterol-sensing domain (Lange and Steck 1998) , because it has a critical role in regulating the degradation of HMG-CoA reductase (Gil et al. 1985; Luskey et al. 1985) and because a mutation in this motif blocks the responsiveness of SCAP to intracellular cholesterol levels (Hua et al. 1996; Nohturfft et al. 1998 ). We determined the genomic structure of all four genes in the regions encoding their sterol-sensing domains, to investigate the relationship between these otherwise distinct proteins.
Materials and methods
dimensional structure (Genome Systems, St. Louis, MO, USA) was used to isolate genomic clones of these three genes. We had determined the genomic structure of SCAP previously (Nakajima et al. 1999) . We screened the PAC library by the polymerase chain reaction (PCR), according to methods described earlier for SCAP, using as primers the following pairs of oppositely oriented oligonucleotides: for HMG-CoA reductase, 5-AATGTTGTCAAGACTTTTTC GAATGC-3 and 5-TTCCAACCACAGATCTTATTGTT ACCA-3; for NPC1, 5-TACAAAGGAACAGAGCGCG AA-3 and 5-TTCACAGGCGCTACGTTCAAA-3; and for Patched, 5-CATCACCACTGTGACGGCTTC-3 and 5-GCTCAATGACTTCCACCTTCGA-3. Escherichia coli cells containing positive clones were cultured in the presence of kanamycin, and PAC DNA was isolated as described previously (Nakajima et al. 1999 ).
Structural analysis of entire human HMG-CoA reductase and the sterol-sensing domains of NPC1 and Patched genes The nucleotide sequences of exons and their boundaries were determined by directly sequencing the PAC clone, using primers designed from the corresponding cDNA sequences. Sequencing was performed by the BigDye Terminator cycle sequencing method, in a 377 ABI Prism automated DNA sequencer (Perkin Elmer, Norwalk, CT, USA). The size of each intron was either determined by direct sequencing of the PAC genomic clones, or estimated by amplification, using LA Taq (Takara, Tokyo, Japan) and oppositely oriented primers located in exons immediately flanking each intron.
Results

Genomic structure of human HMG-CoA reductase
More than 110 kb of the genomic region containing the entire gene was cloned in a single PAC. This gene turned out to be more than 21kb long, about five times the size of its corresponding cDNA, and consists of 20 exons interrupted by 19 introns (Table 1 and Fig. 1A ) (Genbank accession numbers AF2737654,AF273755, AF273756, AF273757, AF273758, AF273759, AF273760, AF273761, AF273762, AF273763, AF273764, and AF273765). Exons ranged in size from 68 to 1809bp. The positions of the introns were identical to those of the hamster HMG-CoA reductase gene (Genbank accession numbers L00166, L00169, and L00170). Sequences at all exon-intron boundaries were compatible with the consensus sequence for splicing junctions, including AG-GT (Mount 1982) .
Comparison of the genomic sequence with the cDNA revealed that exon 1 and the 5Ј half of exon 2 encode the 5Ј-untranslated region (UTR); the protein-coding region extends from the 3Ј portion of exon 2 through exon 19; exon 20 encodes part of the carboxyl-terminal coding region and the entire 3Ј-UTR (Fig. 1B) . Exon 20 contains a polyadenylation site preceded by a polyadenylation signal. The hydrophobic membrane-bound domain at the aminoterminal is encoded by exons 2-10, the flexible linker domain by exons 10 and 11, and the carboxyl-terminal catalytic domain by exons 11-20. The extensive region of homology with three other sterol-sensing proteins, thought to represent the sterol-sensing domain in each case, is encoded by exons 3-7. a The sequences of exon/intron boundaries were determined as described in "Materials and methods". Lowercase letters refer to intronic sequences, and uppercase to exonic sequences b Intron sizes were determined by direct sequencing of the PAC genomic clone, or were estimated by polymerase chain reaction amplification, using LA Taq (asterisks) (TaKaRa, Tokyo, Japan)
Genomic structure of sterol-sensing domains in four sterol-sensing proteins
We had previously shown that five exons encode the sterolsensing domain of human SCAP (Nakajima et al. 1999 ).
In the human HMG-CoA reductase, NPC1, and Patched genes, this domain is encoded by five, four, and five exons, respectively (Fig. 2) . The genomic structure we determined for this region of the human NPC1 gene is identical to that reported by Morris et al. (1999) . However, we identified an intron more than 6.5 kb long, interrupting exon 12 of the human Patched gene; this intron had not been included in the genomic structure described by Hahn et al. (1996) . Comparison of the genomic organization of sterol-sensing domains among the four genes One intron, located at the 3Ј end of the region encoding the sterol-sensing domain, maintained an identical position among the HMG-CoA reductase, SCAP, and NPC1 genes, and another position was identical between HMG-CoA reductase and SCAP (Figs. 3 and 4) . No intron positions in human Patched were identical to those in the other three genes.
We also compared the genomic structure of human sterol-sensing domains with the Caenorhabditis elegans homologue of SCAP (D2013.8; Genbank accession number Z47808; ref. Hua et al. 1996) , NPC1 (F02E8.6; Genbank number U53340; ref. Carstea et al. 1997) , and Patched (ZK675.1 and F21H12.4; GenBank numbers Z46812 and U23176, respectively) and also with the Saccharomyces cerevisiae homologues of HMG-CoA reductase (GenBank M22002) and NPC1 (Lpa11p; GenBank number AAB68099; ref. Carstea et al. 1997) . As shown in Fig. 4 , only one intron position is identical between the human and invertebrate or yeast homologue, i.e., NPC1 and its C. elegans homologue F02E8.6.
Discussion
The presence of sterol-sensing domains in four distinctly different proteins suggests that the genes encoding them may have evolved through exon-shuffling, a process by which exons can be transferred to other genes by recombination events involving introns or transposable elements (Gilbert et al. 1997; Long et al. 1995) . Eukaryotic genes are often larger and more complex than their homologues from simple organisms. Gene elongation during evolution appears frequently to have involved repetition of existing amino acid sequences, often as a result of exon duplication. The structure of many eukaryotic polypeptides suggests that exchanges of structural or functional protein domains at the gene level have resulted in a complex mosaic capable of specifying a variety of different protein modules (Gilbert et al. 1997; Long et al. 1995) . For example, the low-density lipoprotein (LDL) receptor, which is assembled from exonic sequences shared with the C9 component of complement and the epidermal growth factor (EGF) precursor, is a vivid example of such a mosaic protein (Sudhof et al. 1985a,b; Russell et al. 1984) . As further evidence for exon- shuffling, homologous domains are sometimes interrupted by introns in the same position (Sudhof et al. 1985a,b) . The four proteins investigated in our study (NPC1, HMG-CoA reductase, SCAP, and Patched) share a sequence motif that spans five consecutive transmembrane regions Loftus et al. 1997; Lange and Steck 1998) . This motif is thought to function as a sterol-sensing domain, because it plays a critical role in regulating the degradation of HMG-CoA reductase (Gil et al. 1985; Luskey and Stevens 1985) , and because a mutation within this motif blocks the responsiveness of SCAP to intracellular cholesterol levels (Hua et al. 1996; Nohturfft et al. 1998; Brown and Goldstein 1999) . The presence of sterol-sensing domains in four such different proteins supports our view that the genes encoding them probably have evolved through exon-shuffling.
To obtain additional evidence for a common evolutionary origin of the sterol-sensing domains, we determined and compared the genomic structure of that portion of each gene and some of their homologues in lower organisms. The position of one intron, located at the 3Ј end of the region encoding this domain, was identical in three of the four human genes examined, and another position was identical in HMG-CoA reductase and SCAP. However, these positions were not conserved in C. elegans and S. cerevisiae homologues, except in one instance. These data suggest that exon-shuffling that produced a variety of human sterol-sensing domains may have been a recent event in the evolution of higher eukaryotes.
Exon-shuffling may occur through recombination between introns (Sudhof et al. 1985a,b; Lehrman et al. 1987) and/or transposable elements (Moran et al. 1999) . Homologous recombination between repetitive DNA elements dispersed throughout ancestral genomes may have been responsible for generating gene duplications and other DNA rearrangements during evolution (Sudhof et al. 1985a,b) . For example, Alu repeats, which are present near exons encoding the sterol-sensing domains of the HMGCoA reductase and NPC1 genes (Fig. 2) , may have contributed to the evolution of different sterol-sensing proteins by serving as sites of recombination (Lehrman et al. 1987) . We believe that the evidence presented here supports a hypothesis that sterol-sensing domains were incorporated into several proteins by recent exon-shuffling.
